Anemia in Elderly Epidemiology Forecast 2026-2035

The growing focus on healthy aging has brought increased clinical attention to anemia among older adults, a condition that can significantly influence physical function and quality of life. According to Rishi S. Narayanan et al., 2025, the prevalence of anemia among older adults in India is 61.8%, with significant regional variation reported between 20.6% and 92.1% across different studies. The anemia in elderly epidemiology forecast highlights the expanding need for improved screening, early diagnosis, and targeted management strategies within aging populations.

Anemia in Elderly Epidemiology Forecast Report Coverage

The analyst's “Anemia in Elderly Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of anemia in elderly. It projects the future incidence and prevalence rates of anemia in elderly cases across various populations. The study covers age, gender, and type as major determinants of anemia in elderly population. The report highlights patterns in the prevalence of anemia in elderly over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of anemia in elderly in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Anemia in Elderly Understanding: Disease Overview

Anemia in the elderly is a common hematological condition characterized by reduced hemoglobin levels in individuals typically aged 60 years and older. It arises from diverse underlying causes, including nutritional deficiencies, chronic inflammatory disorders, renal insufficiency, and bone marrow dysfunction. The condition may present with symptoms such as fatigue, weakness, cognitive decline, and decreased physical performance, although some older adults remain asymptomatic. Age-related physiological changes and multiple comorbidities contribute to increased susceptibility. In older populations, anemiais associated with higher risks of hospitalization, functional impairment, and mortality, making early recognition and comprehensive evaluation essential for effective clinical management.

Anemia in Elderly Epidemiology Perspective

The anemia in elderly epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for anemia in elderly epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for anemia in elderly and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Anemia in elderly is a multifactorial disorder characterized by reduced hemoglobin levels, increased risk after 50 years of age, and adverse outcomes including impaired cognition, functional decline, higher morbidity, and mortality, as per Roy A. Daniel (2023).
• According to Roy A. Daniel (2023), global prevalence among elderly is 23.9%, affecting about 164 million people, with approximately 80% of older adults expected to reside in low- and middle-income countries by 2050, indicating a rising global burden.
• According to Anushikha Dhankhar et al. (2025), national prevalence in India is approximately 49.92%, with higher prevalence among women (53.9%) than men (45.8%), and nutritional anemia accounting for 63.5% of cases, with iron deficiency being the most common cause (51.8%).
• As per Debashis P Sahoo et al. (2025), age-wise prevalence increases significantly from 18.5% in individuals aged 65-79 years to 42.3% in those aged ≥80 years, indicating a strong positive association between advancing age and anemia prevalence.
• As per Eryk Wacka et al. (2024), prevalence varies by population subgroup, with about 12% in community-dwelling elderly, 40% in hospitalized patients, and 47% in nursing home residents, and a global mean prevalence of approximately 17%, reflecting higher burden in institutionalized populations.

Country-wise Anemia in Elderly Epidemiology Segment

The anemia in elderly epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Developed healthcare systems such as the United States and the United Kingdom provide valuable insight into the epidemiological burden of anemia among older adults. In the United States, around 12.5% of adults aged 60 years and older are affected by anemia, reflecting a notable clinical concern within aging populations. In the United Kingdom, approximately 6-6.5% of the general population experiences anemia, with prevalence rising significantly among adults aged 70 years and older. Additionally, large cohort analyses from the UK Biobank involving more than 200,000 participants aged 60 years and above further highlight the growing clinical relevance of anemia in older populations.

Anemia in Elderly: Treatment Overview

Treatment of anemia in the elderly focuses primarily on identifying and addressing the underlying cause. Management may include iron supplementation for iron deficiency anemia, vitamin B12 or folate replacement for nutritional deficiencies, and erythropoiesis-stimulating agents in cases associated with chronic kidney disease. Patients with anemia linked to chronic inflammatory conditions or malignancies often require targeted management of the underlying disorder. In severe cases, blood transfusions may be used to rapidly correct hemoglobin levels and relieve symptoms. Treatment strategies also emphasize nutritional support, careful monitoring of comorbidities, and individualized care to improve the quality of life and reduce complications in older adults.

Key Questions Answered

• What are the key findings of anemia in elderly epidemiology in the 8 major markets?
• What will be the total number of patients with anemia in elderly across the 8 major markets during the forecast period?
• What was the country-wise anemia in elderly epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of anemia in elderly patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of anemia in elderly during the forecast period of 2026-2035?
• What are the currently available treatments for anemia in elderly?
• What are the disease risks, signs, symptoms, and unmet needs of anemia in elderly?

Scope of the Anemia in Elderly Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of anemia in elderly based on several factors.
• Anemia in Elderly Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• Anemia in elderly report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.